Abstract |
The most recently discovered interferon (IFN) family, type III IFNs or lambda IFNs (IFN-λs) are caused by viral infection and act in mucosal barriers, such as the respiratory tract. In this study, we assessed the serum levels of IFN-λs in new coronavirus disease-2019 (COVID-19) patients. Sixty-four COVID-19 patients were enrolled in this study. All cases were divided into the intensive care unit (ICU) and non-ICU groups according to their symptoms. Fourteen samples of healthy controls were also included. The serum levels of IFN-λ1 and IFN-λ2 were analyzed by specific enzyme-linked immunosorbent assay (ELISA) kits. The concentrations of IFN-λ1 and IFN-λ2 induced in the serum of non-ICU patients (836.7 ± 284.6 and 798.8 ± 301.5 pg/mL, respectively) were higher than found in ICU patients (81.57 ± 34.25 and 48.32 ± 28.13 pg/mL, respectively) (P = 0.004 and P = 0.006, respectively) and healthy controls (85.57 ± 33.63 and 65.82 ± 21.26 pg/mL, respectively) (P = 0.03 and P = 0.04, respectively). Meanwhile, no significant differences were found in the concentration of both cytokines between the ICU patients and healthy controls. We conclude that higher levels of IFN-λs are associated with decreased clinical manifestations in COVID-19 patients. These cytokines could be a promising therapeutic agent to avoid the overwhelming consequences of COVID-19.
|
Authors | Mehdi Shahbazi, Parviz Amri Maleh, Mojgan Bagherzadeh, Zahra Moulana, Mahdi Sepidarkish, Maryam Rezanejad, Mohammad Mirzakhani, Soheil Ebrahimpour, Hosein Ghorbani, Zahra Ahmadnia, Mostafa Javanian, Masomeh Bayani, Mousa Mohammadnia-Afrouzi |
Journal | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
(J Interferon Cytokine Res)
Vol. 41
Issue 4
Pg. 149-152
(04 2021)
ISSN: 1557-7465 [Electronic] United States |
PMID | 33885337
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- IFNL1 protein, human
- IFNL2 protein, human
- Interleukins
- Interferons
|
Topics |
- Adult
- Aged
- COVID-19
(blood, prevention & control)
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Interferons
(blood)
- Interleukins
(blood)
- Male
- Middle Aged
- SARS-CoV-2
(metabolism)
|